SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-763801
Filing Date
2016-11-09
Accepted
2016-11-09 08:58:06
Documents
72
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d228910d10q.htm 10-Q 691544
2 EX-31 d228910dex31.htm EX-31 6620
3 EX-32 d228910dex32.htm EX-32 4414
  Complete submission text file 0001193125-16-763801.txt   4610566

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT mnkd-20160930.xml EX-101.INS 682115
5 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20160930.xsd EX-101.SCH 58990
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnkd-20160930_cal.xml EX-101.CAL 78658
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnkd-20160930_def.xml EX-101.DEF 358173
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20160930_lab.xml EX-101.LAB 447915
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20160930_pre.xml EX-101.PRE 417685
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 161982907
SIC: 2834 Pharmaceutical Preparations